Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
20.24
0.47 (2.38%)
At close: Aug 15, 2025, 3:59 PM
20.22
-0.10%
After-hours: Aug 15, 2025, 04:20 PM EDT
Enliven Therapeutics Fail-to-Deliver
Total FTD Shares
12.35K
Below Average
FTD / Avg. Volume
2.47%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Enliven Therapeutics Inc. has
12,351
shares failed to deliver, representing 2.47%
of the average daily volume of
500,311
shares. Over the past year, the monthly average FTD is
8,004
shares, with the current level 54% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 23 | 12.35K | +2141.56% |
Jun 27, 2025 | 20.68 | 551 | -99.19% |
May 30, 2025 | 17.77 | 67.96K | +3119.19% |
Apr 30, 2025 | 18.94 | 2.11K | +146.90% |
Mar 28, 2025 | 21.07 | 855 | +1985.37% |
Feb 28, 2025 | 20.83 | 41 | -99.89% |
Jan 31, 2025 | 21.86 | 38.68K | +1837.11% |
Dec 30, 2024 | 22.39 | 2K | -47.24% |
Nov 21, 2024 | 25.41 | 3.79K | +551.46% |
Oct 30, 2024 | 28.39 | 581 | -67.49% |
Sep 30, 2024 | 25.54 | 1.79K | +6773.08% |
Aug 19, 2024 | 23.53 | 26 | -97.74% |
Jul 30, 2024 | 26.13 | 1.15K | -68.03% |
Jun 28, 2024 | 23.37 | 3.59K | +3386.41% |
May 31, 2024 | 22.57 | 103 | +1044.44% |
Apr 30, 2024 | 17.39 | 9 | -98.02% |
Mar 25, 2024 | 17.78 | 455 | +394.57% |
Feb 29, 2024 | 15.97 | 92 | -94.59% |
Jan 30, 2024 | 16.28 | 1.7K | +169800.00% |
Dec 29, 2023 | 13.84 | 1 | -99.57% |
Nov 30, 2023 | 11.26 | 234 | +27.17% |
Oct 27, 2023 | 10.99 | 184 | +1740.00% |
Sep 25, 2023 | 13.89 | 10 | -88.76% |
Aug 11, 2023 | 17.54 | 89 | -93.51% |
Jul 28, 2023 | 18.7 | 1.37K | +441.90% |
Jun 30, 2023 | 20.41 | 253 | -56.00% |
May 31, 2023 | 18.3 | 575 | +7087.50% |
Apr 28, 2023 | 19.04 | 8 | -99.71% |
Mar 31, 2023 | 21.9 | 2.75K | +623.68% |
Feb 28, 2023 | 21.54 | 380 | n/a |